XpresSpa Group ($XSPA) is the world’s largest provider of airport spa facilities and had to come up with a new market strategy as the coronavirus ravages the world. Where the share steadily increased at the beginning of this year, soon after the spread of the virus it became clear that the company had to change…
This morning pharmaceutical and medicine giant AstraZeneca ($AZN) announced an immediate interruption of the COVID-19 vaccine test during the Phase 3 study, after a participant in from the UK showed severe neurological symptoms of an unexplained disease. As a result, the company has discontinued the standard process in order to review the safety data first.…
Novavax, Inc. ($NVAX) has been one of the biggest pioneers on the pharmaceutical market since the outbreak of the COVID-19 pandemic. This is mainly due to the extreme increase that the NVAX share has seen this year, by growing with a sensational 2000%. As several biotech companies have begun phase 3 clinical trials for an…
Vaxart, Inc. ($VXRT) – a well-known clinical stage biotechnology company developing oral recombinant vaccines that are administered via tablets rather than injections – is breaking the news this morning. The COVID-19 vaccine candidate has shown encouraging results in preclinical research. Vaxart is now announcing a pre-publication of a manuscript on this matter named: “Preclinical Studies…
Anyone who closely follows the situation surrounding the pandemic worldwide knows that in large parts of Europe the number of new cases with COVID-19 is increasing again. UK Health Minister, Matt Hancock, voiced his concerns on English radio today and is particularly appealing to young adults, who are known to be less serious at dealing…
It appears that about 25% of the people in the world do not intend to be vaccinated when a COVID-19 vaccine becomes available. Just under half of people from 27 countries think there will be a vaccine this year. A new poll by market research firm Ipsos shows that there are large differences between countries…
The European Union hopes to receive 30 million doses of a potential corona vaccine by the end of this year, as part of the deal with British manufacturer AstraZeneca. Based on one dose per person, such a first batch would cover 6 to 7 percent of the EU population. The European Commission has signed a…
Sorrento Therapeutics (Ticker: SRNE) acquired SmartPharm this week for $18.6 million. The pharmaceutical company offered approximately 1.76 million shares to SmartPharm for $10.60 each. The motivation for this is to support efforts to further develop antibody treatments for COVID-19 and other diseases. Sorrento claims it has an antibody that grabs and then blocks the virus…
Who would have thought that Syrian golden hamsters could play a significant role in the search for a vaccine that still holds the world in its grip? Earlier today, Johnson & Johnson ($JNJ) announced in the medical journal “Nature Medicine” that in a preclinical study with these small rodents, the candidate vaccine, Ad26.COV2.S, prevented serious…
Breakout Stocks Corona Virus Stocks The world’s largest online market research store “Research and Markets” (R&M) has officially named 15 pharmaceutical companies at the forefront of the quest for the COVID-19 vaccine. Although in some parts of the world the state of the pandemic is slowly improving, future numbers of the virus are increasing and vaccine…
